| Literature DB >> 11567092 |
X Qiu1, C A Janson, W W Smith, S M Green, P McDevitt, K Johanson, P Carter, M Hibbs, C Lewis, A Chalker, A Fosberry, J Lalonde, J Berge, P Brown, C S Houge-Frydrych, R L Jarvest.
Abstract
SB-219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl-tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl-tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital-acquired infections. The full-length enzyme yielded crystals that diffracted to 2.8 A resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 A. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11567092 PMCID: PMC2374228 DOI: 10.1110/ps.18001
Source DB: PubMed Journal: Protein Sci ISSN: 0961-8368 Impact factor: 6.725